October 18th 2024
At ID Week 2024, in a late-breaking presentation, investigators are reporting it is safe to cut the antibiotic regimen in half without endangering patients for these infections.
So You Made the Decision to Implement Vancomycin AUC Dosing. Now What?
Since the vancomycin guideline update, institutional leaders have been faced with the challenge of implementing and monitoring AUC-guided dosing.
Read More
Linezolid Coadministration With Medications for Opioid Use Disorder: A Serotonin Toxicity Tightrope?
February 16th 2023This study characterized the incidence of serotonin syndrome and identified contributing risk factors with combined medications for opioid use disorder (MOUD) and linezolid use.
Read More
Inappropriate Prescribing of Antibiotics Associated with Increased Costs, Adverse Events
February 13th 2023Six respiratory infections are among the most common diagnoses for which antibiotics often are inappropriately prescribed, and new research sheds light on the effects, both in increased risk of adverse events and excess health care costs.
Read More
Challenges in the Management of Mycobacterium abscessus Complex
This pathogen is the third most frequently isolated nontuberculous mycobacteria seen in the United States. Here is a review of how it presents and treatment options.
Read More
FDA Approval of First Fecal Microbiota Product Ensures Safety in Standardization
December 7th 2022Ferring Chief Scientific Officer Dr. Elizabeth Garner explains the FDA approval of recurrent C diff treatment RBX2660 provides more than a treatment option, it’s a promise of safety and standardization.
Watch